NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
1.750
-0.440 (-20.09%)
At close: Sep 17, 2025, 4:00 PM EDT
1.790
+0.040 (2.29%)
After-hours: Sep 17, 2025, 8:00 PM EDT
NovaBay Pharmaceuticals Market Cap
NovaBay Pharmaceuticals has a market cap or net worth of $10.19 million as of September 17, 2025. Its market cap has increased by 324.63% in one year.
Market Cap
10.19M
Enterprise Value
7.23M
1-Year Change
324.63%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since October 26, 2007, NovaBay Pharmaceuticals's market cap has decreased from $76.50M to $10.19M, a decrease of -86.68%. That is a compound annual growth rate of -10.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 12.80M | 341.38% |
| Dec 31, 2024 | 2.90M | 123.08% |
| Dec 29, 2023 | 1.30M | -63.89% |
| Dec 30, 2022 | 3.60M | -78.70% |
| Dec 31, 2021 | 16.90M | -41.92% |
| Dec 31, 2020 | 29.10M | 62.57% |
| Dec 31, 2019 | 17.90M | 35.61% |
| Dec 31, 2018 | 13.20M | -77.70% |
| Dec 29, 2017 | 59.20M | 18.64% |
| Dec 30, 2016 | 49.90M | 612.86% |
| Dec 31, 2015 | 7.00M | -78.46% |
| Dec 31, 2014 | 32.50M | -32.85% |
| Dec 31, 2013 | 48.40M | 43.62% |
| Dec 31, 2012 | 33.70M | -11.32% |
| Dec 30, 2011 | 38.00M | -1.81% |
| Dec 31, 2010 | 38.70M | -19.21% |
| Dec 31, 2009 | 47.90M | 118.72% |
| Dec 31, 2008 | 21.90M | -72.59% |
| Dec 31, 2007 | 79.90M | 4.44% |
| Oct 26, 2007 | 76.50M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |